Zuplenz Drug Interactions
Currently displaying 218 drugs known to have a moderate interaction with Zuplenz (ondansetron).
Moderate interactions with Zuplenz (ondansetron)
Note: Showing generic names only.
A
- abametapir topical
- abarelix
- abiraterone
- adenosine
- albuterol
- alfuzosin
- apalutamide
- arformoterol
- aripiprazole
- asciminib
- asenapine
- astemizole
- atomoxetine
- azithromycin
B
- belzutifan
- bicalutamide
- bisacodyl
- bitolterol
- bosentan
- bosutinib
- brigatinib
- buprenorphine
- butorphanol
C
- capivasertib
- carbamazepine
- casanthranol
- cascara sagrada
- castor oil
- celecoxib
- cenobamate
- chlorpromazine
- cilostazol
- ciprofloxacin
- clarithromycin
- clofazimine
- codeine
- conivaptan
D
- dabrafenib
- darolutamide
- darunavir
- dasatinib
- daunorubicin
- daunorubicin liposomal
- deferasirox
- degarelix
- deutetrabenazine
- dezocine
- donepezil
- doxorubicin
- doxorubicin liposomal
- duvelisib
E
- echinacea
- encorafenib
- entrectinib
- enzalutamide
- epirubicin
- eribulin
- erythromycin
- etravirine
- ezogabine
F
- famotidine
- flecainide
- fluconazole
- fluphenazine
- flutamide
- formoterol
- foscarnet
- fostamatinib
- fostemsavir
G
- galantamine
- gemifloxacin
- gilteritinib
- givinostat
- glasdegib
- glycerin
- glycerol phenylbutyrate
- goserelin
H
I
- idarubicin
- idelalisib
- imatinib
- indacaterol
- inotuzumab ozogamicin
- isavuconazonium
- isoetharine
- isoproterenol
K
L
- lactitol
- lactulose
- lapatinib
- larotrectinib
- lenacapavir
- leniolisib
- lenvatinib
- letermovir
- leuprolide
- levalbuterol
- levofloxacin
- levorphanol
- lisdexamfetamine
- lofexidine
- lomefloxacin
- lonafarnib
- lonapegsomatropin
- loperamide
- lorlatinib
M
- macimorelin
- magnesium citrate
- magnesium hydroxide
- mavacamten
- mavorixafor
- mefloquine
- metaproterenol
- methotrimeprazine
- metronidazole
- midostaurin
- mineral oil
- mitotane
- morphine
- morphine liposomal
N
O
- ofloxacin
- olanzapine
- olaparib
- olodaterol
- olutasidenib
- omaveloxolone
- osilodrostat
- oxaliplatin
- oxcarbazepine
- oxycodone
- oxymorphone
- oxytocin
P
- paliperidone
- palonosetron
- pazopanib
- pentamidine
- perflutren
- perphenazine
- phenolphthalein
- phenytoin
- pimavanserin
- pirbuterol
- pirtobrutinib
- pitolisant
- polyethylene glycol 3350
- polyethylene glycol 3350 with electrolytes
- pralsetinib
- primaquine
- probucol
- prochlorperazine
- promazine
- promethazine
- propafenone
- propofol
- propoxyphene
Q
R
- ranolazine
- relugolix
- repotrectinib
- rifabutin
- rifampin
- rifapentine
- rilpivirine
- risperidone
- ritlecitinib
- ritodrine
- rivastigmine
- romidepsin
- rucaparib
- rufinamide
S
- salmeterol
- senna
- sevoflurane
- solifenacin
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sorafenib
- sotorasib
- stiripentol
- sunitinib
T
- tacrine
- tacrolimus
- tamoxifen
- tebentafusp
- tecovirimat
- telavancin
- telithromycin
- telotristat
- terbinafine
- terbutaline
- terfenadine
- teriflunomide
- tetrabenazine
- thalidomide
- tizanidine
- triclabendazole
- trifluoperazine
- triflupromazine
- trimeprazine
- triptorelin
- trofinetide
V
Zuplenz disease interactions
There are 2 disease interactions with Zuplenz (ondansetron) which include:
More about Zuplenz (ondansetron)
- Zuplenz consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: 5HT3 receptor antagonists
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.